Cargando…

Do Antibiotics Cause Obesity Through Long-term Alterations in the Gut Microbiome? A Review of Current Evidence

PURPOSE OF REVIEW: In this review, we summarize current evidence on the association between antibiotics and the subsequent development of obesity through modulation of the gut microbiome. Particular emphasis is given on (i) animal and human studies and their limitations; (ii) the reservoir of antibi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vallianou, Natalia, Dalamaga, Maria, Stratigou, Theodora, Karampela, Irene, Tsigalou, Christina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Metabolism (M Dalamaga, Section Editor)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093917/ https://www.ncbi.nlm.nih.gov/pubmed/33945146 http://dx.doi.org/10.1007/s13679-021-00438-w

Ejemplares similares

Obesity, Hypovitaminosis D, and COVID-19: the Bermuda Triangle in Public Health
por: Karampela, Irene, et al.
Publicado: (2022)

Understanding the Co-Epidemic of Obesity and COVID-19: Current Evidence, Comparison with Previous Epidemics, Mechanisms, and Preventive and Therapeutic Perspectives
por: Dalamaga, Maria, et al.
Publicado: (2021)

Chronotype and Sleep Quality in Obesity: How Do They Change After Menopause?
por: Verde, Ludovica, et al.
Publicado: (2022)

Long-Term Efficacy and Safety of Anti-Obesity Treatment: Where Do We Stand?
por: Tak, Young Jin, et al.
Publicado: (2021)

Mediterranean Diet and Obesity-related Disorders: What is the Evidence?
por: Muscogiuri, Giovanna, et al.
Publicado: (2022)

Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives
por: Vallianou, Natalia, et al.
Publicado: (2021)

Omics Biomarkers in Obesity: Novel Etiological Insights and Targets for Precision Prevention
por: Aleksandrova, Krasimira, et al.
Publicado: (2020)

Hepatocyte Mitochondrial Dynamics and Bioenergetics in Obesity-Related Non-Alcoholic Fatty Liver Disease
por: Legaki, Aigli-Ioanna, et al.
Publicado: (2022)

From the Ketogenic Diet to the Mediterranean Diet: The Potential Dietary Therapy in Patients with Obesity after CoVID-19 Infection (Post CoVID Syndrome)
por: Barrea, Luigi, et al.
Publicado: (2022)

Effect of the Implementation of a Structured Diet Management Plan on the Severity of Obstructive Sleep Apnea: A Systematic Review
por: Rokou, Aikaterini, et al.
Publicado: (2022)

Healthcare Professional Training Regarding Gestational Weight Gain: Recommendations and Future Directions
por: Olander, Ellinor K., et al.
Publicado: (2021)

The Role of Nutrition on Meta-inflammation: Insights and Potential Targets in Communicable and Chronic Disease Management
por: Ramos-Lopez, Omar, et al.
Publicado: (2022)

Criterion-Related Validity of Field-Based Methods and Equations for Body Composition Estimation in Adults: A Systematic Review
por: Marin-Jimenez, Nuria, et al.
Publicado: (2022)

Prader–Willi Syndrome in Adults: An Update On Nutritional Treatment and Pharmacological Approach
por: Barrea, Luigi, et al.
Publicado: (2022)

Circulating Omentin-1 as a Biomarker at the Intersection of Postmenopausal Breast Cancer Occurrence and Cardiometabolic Risk: An Observational Cross-Sectional Study
por: Christodoulatos, Gerasimos Socrates, et al.
Publicado: (2021)

Vaccine induced thrombotic thrombocytopenia: The shady chapter of a success story
por: Tsilingiris, Dimitrios, et al.
Publicado: (2021)

What are the key points in the association between the gut microbiome and nonalcoholic fatty liver disease?
por: Vallianou, Natalia, et al.
Publicado: (2019)

Commentary: Phosphodiesterase 4 inhibitors as potential adjunct treatment targeting the cytokine storm in COVID-19
por: Dalamaga, Maria, et al.
Publicado: (2020)

The Role of Next-Generation Probiotics in Obesity and Obesity-Associated Disorders: Current Knowledge and Future Perspectives
por: Vallianou, Natalia G., et al.
Publicado: (2023)

Herpes zoster following COVID-19 vaccination in an immunocompetent and vaccinated for herpes zoster adult: A two-vaccine related event?
por: Vallianou, Natalia G., et al.
Publicado: (2022)

Potential implications of lipid nanoparticles in the pathogenesis of myocarditis associated with the use of mRNA vaccines against SARS-CoV-2
por: Tsilingiris, Dimitrios, et al.
Publicado: (2021)

The combination of bromelain and curcumin as an immune-boosting nutraceutical in the prevention of severe COVID-19
por: Kritis, Panagiotis, et al.
Publicado: (2020)

Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights into Epidemiology, Pathogenesis, Therapeutic Perspectives and Challenges
por: Tsilingiris, Dimitrios, et al.
Publicado: (2023)

Mycobiome and Cancer: What Is the Evidence?
por: Vallianou, Natalia, et al.
Publicado: (2021)

Interrelations Between Food Form, Texture, and Matrix Influence Energy Intake and Metabolic Responses
por: Forde, Ciarán G., et al.
Publicado: (2022)

Dietary Interventions for Type 2 Diabetes in South Asian Populations—A Systematic Review
por: Subhan, Fatheema B., et al.
Publicado: (2022)

Gut microbiome and Mediterranean diet in the context of obesity. Current knowledge, perspectives and potential therapeutic targets
por: Tsigalou, Christina, et al.
Publicado: (2021)

Anti-viral treatment for SARS-CoV-2 infection: A race against time amidst the ongoing pandemic
por: Vallianou, Natalia G., et al.
Publicado: (2021)

Effects of Antibiotics upon the Gut Microbiome: A Review of the Literature
por: Konstantinidis, Theocharis, et al.
Publicado: (2020)

Breakthrough infections after COVID-19 vaccination: Insights, perspectives and challenges
por: Amanatidou, Evropi, et al.
Publicado: (2022)

Diagnostic and Prognostic Value of Serum Omentin-1 in Sepsis: A Prospective Study in Critically Ill Patients
por: Karampela, Irene, et al.
Publicado: (2023)

Comment to: Are fetuin-A levels beneficial for estimating timing of sepsis occurrence?
por: Karampela, Irene, et al.
Publicado: (2019)

Could Respiratory Fluoroquinolones, Levofloxacin and Moxifloxacin, Prove to be Beneficial as an Adjunct Treatment in COVID-19?
por: Karampela, Irene, et al.
Publicado: (2020)

Serum bilirubin to fetuin-A ratio as a prognostic biomarker in critically ill patients with sepsis
por: Karampela, Irene, et al.
Publicado: (2021)

Alterations of gut microbiome following gastrointestinal surgical procedures and their potential complications
por: Tsigalou, Christina, et al.
Publicado: (2023)

Circulating Chemerin and Its Kinetics May Be a Useful Diagnostic and Prognostic Biomarker in Critically Ill Patients with Sepsis: A Prospective Study
por: Karampela, Irene, et al.
Publicado: (2022)

Does COVID-19 Involve the Retina?
por: Karampelas, Michael, et al.
Publicado: (2020)

Commentary: Could iron chelators prove to be useful as an adjunct to COVID-19 Treatment Regimens?
por: Dalamaga, Maria, et al.
Publicado: (2020)

Could hyperglycemia-induced cardiac autoimmunity be hidden behind cardiovascular disease in type 1 diabetes mellitus?
por: Vallianou, Natalia, et al.
Publicado: (2019)

Prediabetes screening: Questionable benefits in the golden years
por: Tsilingiris, Dimitrios, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tkld8kfp4oah5gdp3hamdo167q